Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this insightful session on understanding the Evolution in Treatment and Diagnosis of Lung Cancer. Manipal Hospitals, a leader in advanced medical care, is proud to present this initiative led by the esteemed Dr. Lalit Sharma. From conventional approaches to groundbreaking targeted therapies and immunotherapies, lung cancer treatment has undergone a significant transformation, offering renewed hope and improved outcomes for patients worldwide. This session aims to delve into these pivotal advancements, highlighting how a comprehensive understanding of evolving diagnostic tools and therapeutic strategies is paramount for delivering personalized and effective patient care.
The landscape of lung cancer management has been revolutionized by innovations in both diagnosis and treatment. Early detection, often facilitated by advanced imaging and novel biopsy techniques, now paves the way for more precise staging and tailored interventions. Furthermore, the advent of molecular profiling, including Next-Generation Sequencing (NGS), allows healthcare providers to identify specific genetic mutations within tumors, such as EGFR, ALK, ROS1, and BRAF. This precision medicine approach enables the selection of targeted therapies that directly address the underlying drivers of cancer, significantly enhancing efficacy and minimizing side effects compared to traditional chemotherapy.
Join us to gain comprehensive knowledge on the latest best practices in the evolution of lung cancer treatment and diagnosis. Dr. Lalit Sharma will share invaluable insights on navigating this rapidly advancing field, empowering medical professionals with the knowledge to optimize patient care and improve survival rates. Listen to this essential webinar, absorb the shared expertise, and continue to follow Hidoc for more such enriching educational sessions designed to keep you at the forefront of medical innovation.
See More Webinars @ Hidoc Webinars
1.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
2.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
3.
Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
4.
Targeted Combination Shows Promise in Metastatic Kidney Cancer
5.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
1.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
2.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
3.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
4.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
5.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation